<\/a><\/p>\n FAM 2023<\/p>\n The theme for Fibroid Awareness Month 2023 is \u201cBreaking news<\/strong>!\u201d All programs offer emerging insights and dynamic conversations about uterine fibroids and menstrual health. HERE<\/strong><\/a> for all programs.<\/p>\n Featured events are:<\/p>\n *July 7, 2023 at 7:00 PM EDT –<\/strong> Plastics and fibroids<\/strong><\/p>\n With:<\/p>\n Dr. Find a serdar<\/a>Chair, Department of Obstetrics and Gynecology, John J. Sciarra Professor of Obstetrics and Gynecology, Professor of Obstetrics and Gynecology <\/a>i Obstetrics and Gynecology <\/a>at Northwestern Medicine in Chicago, Illinois.<\/p>\n *July 12, 2023 at 7:00 PM EDT – Work Strategies for Menstrual Care<\/strong><\/p>\n With:<\/p>\n Milena Bacalja Perianes<\/a>Founder of HerShare, Impact Mentor at UNICEF Venture Fund and co-founder of Madam\u00ed.<\/p>\n i<\/p>\n Brittany Barreto, Ph.D.<\/a>co-founder and CEO of FemTech Focus, host of the FemTech Focus podcast, and president and founder of FemHealth Insights.<\/p>\n *July 19, 2023 at 7:00 PM EDT – The Black Maternal Health Crisis<\/strong><\/p>\n Dr. Veronica Gillispie-Bell<\/a>, Obstetrician and Gynecologist, Associate Professor at Ochsner Health in New Orleans, Louisiana, Senior Site Chief and Section Chief of Obstetrics and Gynecology at Ochsner Kenner and Director of Quality for Women’s Services for the Ochsner Health System \/Medical Director of the Minimally Invasive Center for the treatment of uterine fibroids. Dr. Gillispie-Bell is also the medical director of the Louisiana Pregnancy-Associated Mortality Review and Perinatal Quality Collaborative for the Louisiana Department of Health.<\/p>\n Tianna Madison<\/a>, two-time Olympian and three-time Olympic gold medalist in track and field. Maternal health advocate.<\/p>\n *July 27, 2023 at 7:00 PM EDT –<\/strong> Fibroids and menopause<\/strong><\/p>\n Dr Lauren Streicher<\/a> is a clinical professor of obstetrics and gynecology at Northwestern University’s Feinberg School of Medicine, a member of the American College of Obstetricians and Gynecologists, a member of the Sexual Medicine Society of North America, Inc. and Top Doctor since 2002.<\/p>\n The story continues<\/p>\n Sateria Venable, founder and CEO of The Fibroid Foundation, will moderate the panels.<\/p>\n You can find registrations for all events here<\/strong><\/a>.<\/p>\n The Fibroid Foundation is advocating for the passage of the Stephanie Tubbs Jones Fibroid Education and Research Act – HR 2007 introduced in the House of Representatives by Representative Yvette D. Clarke (NY-9). The Stephanie Tubbs Jones Uterine Fibroids Education and Research Act will provide $150 million to the National Institutes of Health for fibroid research.<\/p>\n In the United States, an estimated 26,000,000 women between the ages of 15 and 50 have uterine fibroids.1 Uterine fibroids are the most common gynecologic condition in women,2 but treatment options and research funding medical have not yet matched the enormity of the affected community. .<\/p>\n The 2017 study \u201cUterine Fibroids: Burden and Unmet Medical Need\u201d found that \u201cUsing ultrasound screening, the estimated cumulative incidence rate of UF (uterine fibroids) at age 50 is significantly higher in black women (80%) compared to white women (almost 70%).\u201d3 Uterine fibroids account for approximately half of all hysterectomies performed in the United States annually. Data have shown that there are significant cardiovascular risk factors associated with hysterectomy.<\/p>\n According to The Fibroid Foundation, patients suffer in silence. Community members express concern about limited treatment options, the high cost of treatment, insurance coverage, and difficulty finding fibroid specialists. The organization recognizes important health disparities affecting its community and offers support to address them from a unique patient perspective.<\/p>\n The mission of the Fibroid Foundation:<\/p>\n Normalize conversations about menstruation.<\/p>\n Foster a movement for everyone with a womb to thrive.<\/p>\n Eliminate treatment disparities with layered patient support.<\/p>\n Involve family and community in the menstrual health mission<\/p>\n It allows those diagnosed with uterine fibroids to experience a smooth path to treatment with satisfactory results<\/p>\n Arouse joy through defense.<\/p>\n Understanding how and why fibroids develop and ultimately finding a cure.<\/p>\n About the Fibroid Foundation<\/strong><\/p>\n The Fibroid Foundation is a global menstrual health and fibroid advocacy organization celebrating its 10th anniversary in September 2023.<\/p>\n 1. A systematic review of the psychosocial impact of fibroids before and after treatment<\/a><\/p>\n 2. Epidemiology of uterine fibroids – From menarche to menopause<\/a><\/p>\n 3. Uterine fibroids: burden and unmet medical need<\/a><\/p>\n Contact information<\/strong><\/p>\n Venable Satire SOURCE:<\/strong> The Fibroid Foundation<\/p>\n .<\/p>\n View the source version at accesswire.com:
founder
info@fibroidfoundation.org
8444847698<\/p>\n<\/p>\n
<\/a><\/p>\n